The role of FOXP3 of interstitial tissue in the pathogenesis of breast cancer

被引:0
作者
Xiang, Yu-Juan [1 ,2 ]
Feng, Man [3 ]
Liu, Li-Yuan [1 ,2 ]
Wang, Fei [1 ,2 ]
Yu, Li-Xiang [1 ,2 ]
Zhou, Fei [1 ,2 ]
Huang, Shu-Ya [1 ,2 ]
Zheng, Chao [1 ,2 ]
Ye, Chun-Miao [1 ,4 ]
Zhou, Wen-Zhong [1 ,2 ]
Yin, Geng-Shen [1 ]
Ma, Zhong-Bing [1 ,2 ]
Li, Liang [1 ,2 ]
Zhang, Qiang [1 ,2 ]
Fu, Qin-Ye [1 ,2 ]
Yu, Zhi-Gang [1 ,2 ]
机构
[1] Shandong Univ, Hosp 2, Dept Breast Surg, Cheeloo Coll Med, 247 Beiyuan St, Jinan 250033, Peoples R China
[2] Shandong Univ, Inst Translat Med Breast Dis Prevent & Treatment, Jinan, Peoples R China
[3] Shandong Acad Med Sci, Hosp Shandong Acad Med Sci, Affiliated Hosp Shandong First Med Univ 3, Dept Pathol, Jinan, Peoples R China
[4] Shandong Univ, Sch Med, Jinan, Peoples R China
来源
TRANSLATIONAL BREAST CANCER RESEARCH | 2021年 / 2卷
基金
中国国家自然科学基金;
关键词
Breast cancer; FOXP3; lymph node ratio (LNR); REGULATORY T-CELLS; LYMPH-NODE RATIO; CLINICAL-SIGNIFICANCE; PROGNOSTIC-FACTORS; EXPRESSION; PREDICTS; RISK;
D O I
10.21037/tbcr-21-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The study aimed to evaluate the expression level of FOXP3 and the degree of FOXP3 positive lymphocytes in the interstitial tissues of normal breast tissues, primary breast cancer tissues and axillary lymph node metastatic cancer tissues, so as to better clarify FOXP3's role in the process of breast cancer tumorigenesis and progression. Methods: FOXP3 protein expression and FOXP3 positive tumor infiltrating lymphocytes were investigated by immunohistochemistry analysis in normal breast tissues, primary breast cancer tissues and axillary lymph node metastatic cancer tissues achieved from 44 patients. Results: Compared to normal breast tissues, the expression of FOXP3 in interstitial tissues in primary and metastatic cancer tissues was significantly up-regulated. The FOXP3 positive lymphocytes infiltrated interstitial tissues in 30 of 44 (68.2%) specimens of normal breast tissues, 40 of 44 (90.9%) specimens of primary cancer tissues and 42 of 44 (95.5%) specimens of axillary lymph node metastatic cancer tissues. There was linear correlation trend between FOXP3 expression and the process transforming from normal breast epithelium to primary cancer and metastatic cancer, indicating its potential role in the pathogenesis of this disease. And we found that the expression of interstitial FOXP3 in axillary lymph node metastatic cancer site was correlated with the lymph node ratio (LNR), and LNR was higher in the FOXP3 positive expression group than the FOXP3 absent group. Conclusions: Increased FOXP3 expression in cancer interstitial tissues and FOXP3 positive lymphocytes infiltration might have a certain correlation with the development of breast cancer through facilitating immune escape of tumor.
引用
收藏
页数:10
相关论文
共 35 条
  • [1] ALTERED LYMPHOCYTE POPULATIONS IN TUMOR INVADED NODES OF BREAST-CANCER PATIENTS
    ALAM, SM
    CLARK, JS
    GEORGE, WD
    CAMPBELL, AM
    [J]. IMMUNOLOGY LETTERS, 1993, 35 (03) : 229 - 234
  • [2] Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
    Bates, Gaynor J.
    Fox, Stephen B.
    Han, Cheng
    Leek, Russell D.
    Garcia, Jose F.
    Harris, Adrian L.
    Banham, Alison H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5373 - 5380
  • [3] Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
    Bjork Gunnarsdottir, Frida
    Auoja, Nathalie
    Bendahl, Par-Ola
    Ryden, Lisa
    Ferno, Marten
    Leandersson, Karin
    [J]. ONCOIMMUNOLOGY, 2020, 9 (01):
  • [4] Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003)
    Fontenot, Jason D.
    Gavin, Marc A.
    Rudensky, Alexander Y.
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (03) : 986 - 992
  • [5] The FOXP3Δ2 isoform supports Treg cell development and protects against severe IPEX syndrome
    Frith, Katie
    Joly, Anne-Laure
    Ma, Cindy S.
    Tangye, Stuart G.
    Lohse, Zuzana
    Seitz, Christina
    Verge, Charles F.
    Andersson, John
    Gray, Paul
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (01) : 317 - +
  • [6] FOXP3 expression and nodal metastasis of breast cancer
    Goekmen-Polar, Yesim
    Thorat, Mangesh A.
    Sojitra, Payal
    Saxena, Rashmil
    Badve, Sunil
    [J]. CELLULAR ONCOLOGY, 2013, 36 (05) : 405 - 409
  • [7] Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer
    Hinz, Sebastian
    Pagerols-Raluy, Laia
    Oberg, Hans-Heinrich
    Ammerpohl, Ole
    Gruessel, Sandra
    Sipos, Bence
    Gruetzmann, Robert
    Pilarskys, Christian
    Ungefroren, Hendrik
    Saeger, Hans-Detlev
    Mloeppel, Guenter
    Kabelitz, Dieter
    Kalthoff, Holger
    [J]. CANCER RESEARCH, 2007, 67 (17) : 8344 - 8350
  • [8] Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.21492, 10.3322/caac.20115, 10.3322/caac.20107]
  • [9] Prognostic factors for breast cancer and their use in the clinical setting
    Kapoor, A
    Vogel, VG
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (02) : 269 - 281
  • [10] Estrogen receptor α and β are prognostic factors in non-small cell lung cancer
    Kawai, H
    Ishii, A
    Washiya, K
    Konno, T
    Kon, H
    Yamaya, C
    Ono, I
    Minamiya, Y
    Ogawa, J
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (14) : 5084 - 5089